Gleason Group’s Privia Health PRVA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRVA
DCP
RF
RP
Gleason Group's PRVA Position: Q4 2023 in Review
Gleason Group sold out of Privia Health (PRVA) in Q4 2023, closing a stake of 2,150 shares — an estimated $49.5K sold.
Gleason Group first reported a position in PRVA in Q1 2022 and held it in 7 quarters. The position peaked at $73K in Q3 2022. 226 funds tracked by Wall St. Rank hold PRVA as of Q4 2023.
- Gleason Group reported no remaining Privia Health position as of Q4 2023 after selling out during the quarter.
- Gleason Group sold 2,150 Privia Health shares in Q4 2023, an estimated $49.5K.
- Gleason Group first reported a position in Privia Health in Q1 2022 and held it in 7 quarters.
- Gleason Group's Privia Health position peaked at $73K in Q3 2022.
- 226 funds tracked by Wall St. Rank held Privia Health as of Q4 2023.
Based on Gleason Group's 13F filing for Q4 2023, filed 19 Jan 2024.